NCT01781104View on ClinicalTrials.gov

Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions
Constipation
Interventions
DRUG

RM-131

Double blind RM-131 (100 ug) will be delivered subcutaneously once daily for 14 days.

DRUG

Placebo

Placebo delivered subcutaneously once daily for 14 days.

Trial Locations (3)

Unknown

Mayo Clinic Arizona, Scottsdale

Mayo Clinic Florida, Jacksonville

Mayo Clinic Rochester, Rochester

Sponsors
All Listed Sponsors
lead

Motus Therapeutics, Inc.

INDUSTRY